biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Feb 15, 2017 11:09am

127 Views

Post# 25848911

RE:RE:RE:RE:RE:RE:RE:Are Your Orders Reviewed?

Thanks KBC for taking care of that pesky delay with TD stock buy orders. My latest order went right through without a hitch.

I'm a bit surprised they fixed it. After several phone calls, somebody got somebody to review it I think. There really was no reason for it to be reviewed in the first place IMO. There are lots of sketchy penny stocks that don't get reviewed.

Going forward, it might help if none of us did anything goofy on the orders. No 100,000 share market orders! :-)

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute